Patents by Inventor Simona Daly

Simona Daly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230366002
    Abstract: The invention relates to a recombinant yeast wherein the PEP4 gene is inactivated. Said yeast is useful for the production of oligopeptides.
    Type: Application
    Filed: September 27, 2021
    Publication date: November 16, 2023
    Applicant: LESAFFRE ET COMPAGNIE
    Inventors: Simona Daly, Stefano Galliani, Immacolata Busiello, Matteo Grigis, Auro Roberto Tagliani
  • Patent number: 10563270
    Abstract: Disclosed are solid forms of menaquinol and processes for obtaining them by chemical or enzymatic reduction of menaquinone. Said solid forms possess high stability to oxidation which allows effective use of menaquinol in the most common formulations wherein vitamin K2 is used.
    Type: Grant
    Filed: March 18, 2016
    Date of Patent: February 18, 2020
    Assignee: Gnosis S.p.A.
    Inventors: Davide Bianchi, Simona Daly, Niccolo Miraglia, Antonella Trentin, Federica Colzani, Francesca Bollini, Cesare Ponzone
  • Publication number: 20180066326
    Abstract: Disclosed are solid forms of menaquinol and processes for obtaining them by chemical or enzymatic reduction of menaquinone. Said solid forms possess high stability to oxidation which allows effective use of menaquinol in the most common formulations wherein vitamin K2 is used.
    Type: Application
    Filed: March 18, 2016
    Publication date: March 8, 2018
    Applicant: Gnosis S.p.A.
    Inventors: Davide Bianchi, Simona Daly, Niccolo Miraglia, Antonella Trentin, Federica Colzani, Francesca Bollini, Cesare Ponzone
  • Patent number: 8771992
    Abstract: Chondroitin is produced by culturing a recombinant microorganism which is obtained by inactivation of a gene encoding an enzyme responsible for addition of fructose residues to the linear chondroitin polysaccharide in a microorganism producing a fructosylated derivative of chondroitin.
    Type: Grant
    Filed: November 13, 2013
    Date of Patent: July 8, 2014
    Assignee: GNOSIS S.p.A.
    Inventors: Antonio Trilli, Immacolata Busiello, Simona Daly, Francesca Bagatin
  • Publication number: 20140073772
    Abstract: Chondroitin is produced by culturing a recombinant microorganism which is obtained by inactivation of a gene encoding an enzyme responsible for addition of fructose residues to the linear chondroitin polysaccharide in a microorganism producing a fructosylated derivative of chondroitin.
    Type: Application
    Filed: November 13, 2013
    Publication date: March 13, 2014
    Applicant: GNOSIS S.P.A.
    Inventors: Antonio Trilli, Immacolata Busiello, Simona Daly, Francesca Bagatin
  • Patent number: 8609394
    Abstract: Chondroitin is produced by culturing a recombinant microorganism which is obtained by inactivation of a gene encoding an enzyme responsible for addition of fructose residues to the linear chondroitin polysaccharide in a microorganism producing a fructosylated derivative of chondroitin.
    Type: Grant
    Filed: June 24, 2011
    Date of Patent: December 17, 2013
    Assignee: Gnosis S.p.A.
    Inventors: Antonio Trilli, Immacolata Busiello, Simona Daly, Francesca Bagatin
  • Publication number: 20120010399
    Abstract: Chondroitin is produced by culturing a recombinant microorganism which is obtained by inactivation of a gene encoding an enzyme responsible for addition of fructose residues to the linear chondroitin polysaccharide in a microorganism producing a fructosylated derivative of chondroitin.
    Type: Application
    Filed: June 24, 2011
    Publication date: January 12, 2012
    Applicant: GNOSIS S.P.A.
    Inventors: Antonio Trilli, Immacolata Busiello, Simona Daly, Francesca Bagatin
  • Patent number: 7718407
    Abstract: A process for the preparation of vitamin K2 (MK-7) comprising the culture of Bacillus subtilis mutant strain GN13/72-DSM 17766 deposited on Dec. 5, 2005 at the DSMZ.
    Type: Grant
    Filed: December 8, 2006
    Date of Patent: May 18, 2010
    Assignee: GNOSIS S.p.A.
    Inventors: Alberto Benedetti, Simona Daly, Roberto Xaiz, Hermes Pagani
  • Publication number: 20070154998
    Abstract: A process for the preparation of vitamin K2 (MK-7) comprising the culture of Bacillus subtilis mutant strain GN13/72-DSM 17766 deposited on Dec. 5, 2005 at the DSMZ.
    Type: Application
    Filed: December 8, 2006
    Publication date: July 5, 2007
    Inventors: Alberto Benedetti, Simona Daly, Roberto Xaiz, Hermes Pagani